Rotavirus vaccine
The rotavirus vaccine is a vaccine used to protect against rotavirus infections, which are the leading cause of severe diarrhea among young children. The vaccines are safe and effective, and they have significantly reduced the incidence of rotavirus-related hospitalizations and deaths worldwide.
History[edit]
The first rotavirus vaccine, RotaShield, was licensed in the United States in 1998 but was withdrawn from the market in 1999 due to an increased risk of intussusception, a type of bowel obstruction. Subsequent vaccines, including Rotarix and RotaTeq, were developed and have been shown to be safe and effective.
Types of Rotavirus Vaccines[edit]
There are two main types of rotavirus vaccines currently in use:
- Rotarix: A monovalent vaccine derived from a human rotavirus strain. It is administered in two doses, typically at 2 and 4 months of age.
- RotaTeq: A pentavalent vaccine that contains five rotavirus strains. It is administered in three doses, typically at 2, 4, and 6 months of age.
Mechanism of Action[edit]
Rotavirus vaccines work by stimulating the immune system to produce antibodies against rotavirus. This helps prevent future infections by the virus. The vaccines are administered orally, which mimics the natural infection route of the virus and helps induce mucosal immunity in the gut.
Efficacy[edit]
Clinical trials and real-world studies have shown that rotavirus vaccines are highly effective in preventing severe rotavirus gastroenteritis. The vaccines have been shown to reduce hospitalizations due to rotavirus by 85-90% in countries where they are routinely used.
Safety[edit]
Rotavirus vaccines are generally well-tolerated. The most common side effects are mild and include irritability, mild diarrhea, and vomiting. The risk of intussusception is very low, and the benefits of vaccination far outweigh the risks.
Global Impact[edit]
The introduction of rotavirus vaccines has had a significant impact on global child health. In countries with high vaccine coverage, there has been a dramatic reduction in rotavirus-related hospitalizations and deaths. The World Health Organization (WHO) recommends that rotavirus vaccines be included in all national immunization programs.
Also see[edit]
-
Rotavirus vaccine
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian